Grant Zeng, CFA
Research analyst, CFA, biotech, small-cap

Why We Think Arrowhead Research Is Undervalued

In my recent article, I discussed Tekmira Pharmaceuticals (TKMR), a biopharmaceutical company focused on RNAi therapeutics. In this article, I will discuss another small cap biotech company Arrowhead Research Corp (NASDAQ:ARWR) which is focused on both RNAi therapeutic and small molecule delivery.

Three Platform Technologies Provide Multiple Applications of Targeted Therapy

Arrowhead Research Corporation is a clinical stage biotech company focused on oncology, obesity, and infectious disease.

Over the years, Arrowhead has developed three proprietary drug delivery platform technologies: Homing Peptides™, Dynamic Polyconjugates (DPCs) ™, and RONDEL™. All three technologies are actively targeted delivery vehicles that can deliver small molecule and siRNA (small interfering RNA) drugs into tissues and cell types of interest while avoiding non-specific

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details